Related Experiment Video
Updated: Oct 20, 2025

08:25
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
6.9K
Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta)
Ji-Eun Seo1, Kelly Davis2, Pritpal Malhi2
1Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079, USA.
Toxicology
|September 12, 2021
Summary
Primary macaque hepatocytes (PMHs) effectively detect genotoxicants, mirroring human cell performance. This method supports using non-human primate tissues for crucial chemical safety assessments.
Area of Science:
- Toxicology
- Hepatology
- Genetics
Background:
- Non-human primates (NHPs) share physiological and genetic similarities with humans, making them valuable research models.
- Primary hepatocytes are crucial for studying drug metabolism and toxicity.
Purpose of the Study:
- To establish a method for isolating primary hepatocytes from rhesus macaque livers.
- To evaluate the utility of primary macaque hepatocytes (PMHs) as a surrogate for primary human hepatocytes (PHHs) in genotoxicity testing.
Main Methods:
- In situ whole liver perfusion to isolate PMHs from rhesus macaques.
- Treatment of PMHs with known genotoxic and non-genotoxic compounds.
- DNA damage assessment using the CometChip assay.
- Quantification of comet data using benchmark dose (BMD) modeling.
Main Results:
- PMHs demonstrated comparable sensitivity and specificity to PHHs in detecting direct-acting and indirect-acting genotoxicants.
- BMD50 values revealed species-specific differences in DNA damage potency, particularly for direct-acting compounds.
- The study successfully established a practical method for isolating and utilizing PMHs.
Conclusions:
- PMHs serve as a reliable surrogate for PHHs in evaluating the genotoxic hazards of chemical substances.
- This method maximizes the utility of NHP tissues in toxicological research.
- The findings support the use of PMHs in preclinical and translational safety studies for humans.

